(Q28335923)

1

0 references

K Klimm

2

0 references

L B Rice

3

0 references

M J Ferraro

4

0 references

R C Moellering

Antimicrobial Agents and Chemotherapy

5

0 references

language of work or name

English

0 references

publication date

June 1990

0 references

published in

0 references

volume

34

0 references

issue

6

0 references

page(s)

1154-9

0 references

cites work

Broth microdilution testing of susceptibilities to 30 antimicrobial agents of Mycobacterium avium strains from patients with acquired immune deficiency syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171776

In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620.

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171776

Susceptibility of Legionella pneumophila to ofloxacin in vitro and in experimental Legionella pneumonia in guinea pigs

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171776

In vitro activities of ICI 194008 and ICI 193428, two new cephem antimicrobial agents

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171776

Comparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969).

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171776

In vitro activities of PD 117,596 and reference antibiotics against 448 clinical bacterial strains

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171776

In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171776

Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospital

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171776

In vitro evaluation of WIN 57273, a new broad-spectrum fluoroquinolone

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171776

Enterococcal superinfection in patients treated with ciprofloxacin

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171776

In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171776

In-vitro activity of PD 117558, a new quinolone against bacterial isolates from cancer patients

2 June 2018

1 reference

12 December 2020

In vitro activity of CI-934, a new quinolone antimicrobial, against gram-positive bacteria

1 reference

12 December 2020

The in-vitro activity of PD127,391, a new quinolone

1 reference

12 December 2020

In-vitro and in-vivo activities of T-3262, a new pyridone carboxylic acid

1 reference

12 December 2020